Filter results
Type
Audience
Last updated
Topics
-
Release of the Australian Government's response to the Review of COVID-19 Vaccine and Treatment Purchasing and Procurement
News and media27 February 2023 - The Australian Government has responded to the Halton review into COVID-19 vaccine and treatment procurement.
-
ATAGI statement on the intradermal use of Imojev Japanese encephalitis vaccine
Resources › Publications16 July 2024 - ATAGI has reviewed the evidence on the intradermal (ID) administration of Japanese encephalitis (JE) vaccines and considered the potential use of Imojev as a dose-sparing mechanism, in the context of the risk of future outbreaks, expanded eligibility in risk areas, and ongoing supply considerations.
-
Statement on the clinical use of zoster vaccine in older adults in Australia
Resources › Publications16 July 2024 - This ATAGI clinical statement provides recommendations for the zoster vaccine and Shingrix vaccine.
-
State and territory vaccine objection (conscientious objection) data
Resources › Publications26 March 2018 - These documents provide conscientious objection data by state and territory for 2012 to 2015. The data is sourced from the Australian Immunisation Register (AIR).
-
Adolescent ‘booster’ dose of diphtheria-tetanus-pertussis (dTpa) vaccine - brochure
Resources › Publications17 December 2019 - This brochure provides information about the diphtheria-tetanus-pertussis (dTpa) vaccine for adolescents.
-
Young people's health news
Topics › Young people's health18 December 2024 - Read our latest news items related to young people's health.
-
ATAGI expanded guidance on temporary medical exemptions for COVID-19 vaccines
Resources › Publications29 April 2024 - The Australian Technical Advisory Group on Immunisation (ATAGI) has developed guidance for providers on acute major medical conditions that warrant a temporary medical exemption relevant for COVID-19 vaccines.
-
Respiratory syncytial virus (RSV) infection
Diseases11 April 2025 - Find out how we define and monitor cases of RSV infection, and where you can learn more about this disease.
-
ATAGI statement on the transition from quadrivalent to trivalent seasonal influenza vaccines in Australia
Resources › Publications29 August 2024 - Australian Technical Advisory Group on Immunisation (ATAGI) statement about the transition from quadrivalent to trivalent seasonal influenza vaccines in Australia.
-
Mandatory reporting of Japanese encephalitis virus vaccines to the Australian Immunisation Register began on 21 December 2022
News and media2 February 2024 - From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).